Evidence map›Paper›PMID 21329461›Full record

ReviewOmics : a journal of integrative biology2011

Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer.

Andrew N Lane, Teresa W-M Fan, Michael Bousamra, Richard M Higashi, Jun Yan, Donald M Miller

Open access · greenAbstract readReview
In one paragraph

Review in Omics : a journal of integrative biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Quantitative NMR Methods in Metabolomics.Handbook of experimental pharmacology · 2023
    Article
  7. Practical Aspects of NMR-Based Metabolomics.Handbook of experimental pharmacology · 2023
    Article
  8. Review
  9. Article
  10. NMR-Based Metabolomics.Advances in experimental medicine and biology · 2021
    Article
  11. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming.Frontiers in molecular biosciences · 2021
    Review
  12. Review
  13. Article
  14. Inferring Gene Regulatory Networks of Metabolic Enzymes Using Gradient Boosted Trees.IEEE journal of biomedical and health informatics · 2020
    Article
  15. Article
  16. High-Throughput Metabolomics by 1D NMR.Angewandte Chemie (International ed. in English) · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrew N LaneJG Brown Cancer Center, Department of Chemistry, University of Louisville, Louisville, Kentucky 40202, USA. Anlane01@louisville.edu
Teresa W-M Fan
Michael Bousamra
Richard M Higashi
Jun Yan
Donald M Miller
University of Louisville Hospital · USUniversity of Louisville · US

Funding

PROJ 12: STEM CELL-BASED VACCINE FOR CANCER PROPHYLAXISP20RR018733 · NCRR · UNIVERSITY OF LOUISVILLE · PI TRENT, JOHN O · 2003 to 2011
$18.9M
Biochemical Mechanisms of Se Anticancer Activity in LungR01CA118434 · NCI · UNIVERSITY OF LOUISVILLE · PI FAN, TERESA WHEI-MEI · 2008 to 2011
$1.4M
NCI NIH HHS 1R01CA118434-01A2NCI NIH HHS 3R01CA118434-02S1NCRR NIH HHS P20RR018733
6 · The paper itself

Abstract

Metabolomics provides a readout of the state of metabolism in cells or tissue and their responses to external perturbations. For this reason, the approach has great potential in clinical diagnostics. Clinical metabolomics using stable isotope resolved metabolomics (SIRM) for pathway tracing represents an important new approach to obtaining metabolic parameters in human cancer subjects in situ. Here we provide an overview of the technology development of labeling from cells in culture and mouse models. The high throughput analytical methods NMR and mass spectrometry, especially Fourier transform ion cyclotron resonance, for analyzing the resulting metabolite isotopomers and isotopologues are described with examples of applications in cancer biology. Special technical considerations for clinical applications of metabolomics using stable isotope tracers are described. The whole process from concept to analysis will be exemplified by our on-going study of nonsmall cell lung cancer (NSCLC) metabolomics. This powerful new approach has already provided important new insights into metabolic adaptations in lung cancer cells, including the upregulation of anaplerosis via pyruvate carboxylation in NSCLC.

Indexed as

Isotope LabelingMetabolomicsResearch DesignAnimalsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsResearch

Identifiers

PMID21329461
PMCPMC3125551
OpenAlexW2057034623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.